ArticleVaccine: X2024

Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study.

Sitthichai Kanokudom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.